Results
19
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
19 companies
Torrent Pharmaceuticals
Market Cap: ₹1.1t
Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,321.80
7D
2.4%
1Y
25.8%
Xiamen Amoytop Biotech
Market Cap: CN¥30.8b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥75.60
7D
-4.3%
1Y
24.9%
Ipca Laboratories
Market Cap: ₹353.3b
A pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia.
IPCALAB
₹1,392.40
7D
-3.5%
1Y
3.9%
Ajanta Pharma
Market Cap: ₹345.4b
A specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages.
AJANTPHARM
₹2,765.80
7D
3.1%
1Y
24.8%
Gan & Lee Pharmaceuticals
Market Cap: CN¥28.9b
A biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.
603087
CN¥48.48
7D
7.8%
1Y
-3.1%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥16.1b
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.
000403
CN¥22.04
7D
-2.2%
1Y
-24.8%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥11.9b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥53.01
7D
2.2%
1Y
-5.4%
Blue Jet Healthcare
Market Cap: ₹118.9b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹685.40
7D
-8.7%
1Y
76.7%
Xiamen Kingdomway Group
Market Cap: CN¥9.7b
Engages in the manufacturing and sale of the nutrition and health products in China and internationally.
002626
CN¥15.98
7D
0.4%
1Y
2.8%
Granules India
Market Cap: ₹110.4b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly.
532482
₹455.50
7D
-5.2%
1Y
7.7%
Aurisco PharmaceuticalLtd
Market Cap: CN¥8.5b
Engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API’s), and formulations catering to the pharmaceutical market worldwide.
605116
CN¥20.96
7D
-3.1%
1Y
-14.1%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.0b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥14.96
7D
2.3%
1Y
31.1%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.0b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥16.08
7D
-6.4%
1Y
-39.7%
Ami Organics
Market Cap: ₹89.3b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
AMIORG
₹1,090.30
7D
-0.5%
1Y
77.2%
Consun Pharmaceutical Group
Market Cap: HK$7.9b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.50
7D
-1.9%
1Y
62.4%
Akums Drugs and Pharmaceuticals
Market Cap: ₹82.5b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹524.45
7D
3.7%
1Y
n/a
Innova Captab
Market Cap: ₹50.8b
An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.
INNOVACAP
₹888.20
7D
-1.8%
1Y
87.7%
Beijing Kawin Technology Share-Holding
Market Cap: CN¥4.1b
A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.
688687
CN¥24.57
7D
-9.1%
1Y
-17.9%
Essex Bio-Technology
Market Cap: HK$2.6b
An investment holding company, develops, manufactures, and sells biologic drugs in the People’s Republic of China, Hong Kong, and internationally.
1061
HK$4.54
7D
11.3%
1Y
97.4%